JOSÉ ANTONIO
HERRERO CALVO
Profesor asociado de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (54)
2021
-
Control of phosphorus and prevention of fractures in the kidney patient
Nefrologia, Vol. 41, Núm. 1, pp. 7-14
-
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis
Journal of Medical Economics, Vol. 24, Núm. 1, pp. 1240-1247
-
Hemodialysis Centers Guide 2020
Nefrologia, Vol. 41, pp. 1-77
2020
-
Association between kidney function, nutritional status and anthropometric measures in older people
BMC Geriatrics, Vol. 20
-
Chronic kidney disease in the context of multimorbidity patterns: The role of physical performance
BMC Geriatrics, Vol. 20
-
Initiating renal replacement therapy through incremental haemodialysis: Protocol for a randomized multicentre clinical trial
Trials, Vol. 21, Núm. 1
2019
-
Clinical profile of women diagnosed with Fabry disease non receiving enzyme replacement therapy
Medicina Clinica, Vol. 153, Núm. 2, pp. 47-55
2017
-
Testosterone deficiency in dialysis patients: Difference between dialysis techniques
Nefrologia, Vol. 37, Núm. 5, pp. 526-530
2015
-
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Economics Review, Vol. 5, Núm. 1
-
Cost-effectiveness analysis of lanthanum carbonate versus sevelamer hydrochloride in the treatment of hyperphosphatemia in patients with end-stage renal disease in Spain
Pharmacoeconomics - Spanish Research Articles, Vol. 12, Núm. 1, pp. 11-22
-
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies
Molecular Genetics and Metabolism, Vol. 114, Núm. 2, pp. 248-258
2014
-
Fallo precoz de trasplante renal y vuelta a diálisis peritoneal: Estudio preliminar de permeabilidad y eficacia de diálisis
Nefrologia, Vol. 34, Núm. 1, pp. 105-109
-
Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection
Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056
-
Influencia de las soluciones glucosadas en el desarrollo de hiperglucemia en diálisis peritoneal. Comportamiento de la hemoglobina glucosilada y el perfil lipídico
Nefrologia
2013
-
Activación de los receptores de vitamina Den la optimización del hiperparatiroidismo secundario en diálisis
Nefrologia, Vol. 33, Núm. 4, pp. 571-584
-
Bisphenol a in chronic kidney disease
International Journal of Nephrology, Vol. 2013
2012
-
Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol - a preliminary study
Clinical Nephrology, Vol. 78, Núm. 2, pp. 93-99
-
Estudio Español sobre anticoagulación en hemodiálisis
Nefrologia, Vol. 32, Núm. 2, pp. 143-152
2011
-
Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease
European Journal of Echocardiography, Vol. 12, Núm. 9, pp. 671-677